Ricerca
Studio osservazionale multicentrico sulla bronchiolite nella Regione Emilia Romagna (SOMBRERO)
Multicentre observational study on bronchiolitis in the Emilia Romagna Region (SOMBRERO STUDY)
Roberto Sacchetti1, nadia Lugli2, Stefano Alboresi3, Mariassunta Torricelli4, Oreste Capelli5, Lucia Borsari6, Alessandro Ballestrazzi3
1Pediatra di libera scelta, Piacenza; 2Pediatra di libera scelta, Modena; 3Pediatra di libera scelta, Bologna
4Pediatra di libera scelta, Reggio Emilia; 5Governo Clinico, AUSL di Modena
6Scuola di Specializzazione in Igiene e Medicina Preventiva, Università di Modena
Giugno 2015 - pagg. 376 -381
Abstract
Introduction - A cross-sectional study was conducted to evaluate the current clinical practice
in outpatient management of patients with bronchiolitis among paediatricians. The
evaluation was conducted taking into account clinical, therapeutic and qualitative outcomes
and adherence to international guidelines.
Materials and methods - The study was conducted between January 1, 2012 - May 31, 2013 in 4 Local Health Units in Emilia Romagna. All new cases of bronchiolitis in children aged < 12 months were registred by the paediatricians who participated in the study. Socio-demographic data, clinical parameters, therapy and hospital admission information were collected.
Results - Twenty-five paediatricians participated in the study and 109 cases of acute bronchiolitis were included. The mean age of patients was 4.6 months (range 1-9). The median clinical score of severity was 4.6 (range 1-9) and the highest scores were observed in 12 patients aged < 6 months. In 71.6% of cases no lab or instrumental exams were performed; the most used test was oxygen saturation measurement, SpO2 (28.4%). Beta-2 adrenergic agonists were the most common prescribed therapy (94.3%), followed by inhaled corticosteroids (54%), oral systemic corticosteroids (52%), antibiotics (34%) and adrenaline (9.2%). Seventy percent of patients were followed up within 48 hours. Hospital admission occurred in 27.6% of cases; clinical score of severity turned out to be the most useful criteria for hospitalization.
Conclusions - The results of the study show appropriate outpatient management of bronchiolitis by paediatricians: adequate use of diagnostic exams, appropriate follow-up schedules and hospitalizations. The analysis of therapeutic approaches highlights a higher use of beta2-adrenergic agonists and corticosteroids than indicated in international guidelines.
Materials and methods - The study was conducted between January 1, 2012 - May 31, 2013 in 4 Local Health Units in Emilia Romagna. All new cases of bronchiolitis in children aged < 12 months were registred by the paediatricians who participated in the study. Socio-demographic data, clinical parameters, therapy and hospital admission information were collected.
Results - Twenty-five paediatricians participated in the study and 109 cases of acute bronchiolitis were included. The mean age of patients was 4.6 months (range 1-9). The median clinical score of severity was 4.6 (range 1-9) and the highest scores were observed in 12 patients aged < 6 months. In 71.6% of cases no lab or instrumental exams were performed; the most used test was oxygen saturation measurement, SpO2 (28.4%). Beta-2 adrenergic agonists were the most common prescribed therapy (94.3%), followed by inhaled corticosteroids (54%), oral systemic corticosteroids (52%), antibiotics (34%) and adrenaline (9.2%). Seventy percent of patients were followed up within 48 hours. Hospital admission occurred in 27.6% of cases; clinical score of severity turned out to be the most useful criteria for hospitalization.
Conclusions - The results of the study show appropriate outpatient management of bronchiolitis by paediatricians: adequate use of diagnostic exams, appropriate follow-up schedules and hospitalizations. The analysis of therapeutic approaches highlights a higher use of beta2-adrenergic agonists and corticosteroids than indicated in international guidelines.
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Glezen WP, Taber LH, Frank AL, Kasel JA.
Risk of primary infection and reinfection with
respiratory syncytial virus. Am J Dis Child
1986;140(6):543-6.
2. American Academy of Pediatrics (AAP).
Diagnosis and management of bronchiolitis.
Pediatrics 2006;118(4):1774-93.
3. Bronchiolitis Guideline Team, Cincinnati
Children’s Hospital Medical Center. Evidence-
based care guideline for management of
bronchiolitis in infants 1 year of age or less
with a first time episode, Bronchiolitis Pediatric
Evidence-Based Care Guidelines, Cincinnati
Children’s Hospital Medical Center. Guideline
1, 2010;1-16.
4. Scottish Intercollegiate Guidelines Network.
Guideline 91. Bronchiolitis in children:
a national clinical guideline, 2006.
5. Lakhanpaul M, Armon K, Eclleston P, et al.
An Evidence Based Guideline for the management
of children presenting with acute
breathing difficulty. University of Nottingham.
www.Nottigham.ac..uk/paedratic-guideline/
breathguideline.pdf.
6. Wright M, Piedimonte G. Respiratory
syncyntial virus prevention and therapy: past,
presente and future. Pediatr Pulmonol 2011;
46(4):324-47.
7. Lanari M, Giovannini M, Giuffrè L, et al. For
the R.A.DA.R. Study Group. Prevalance of Respiratory
Syncitial Virus Infection in Italian infants
hospitalized for acute lower respiratory
tract infection, and association between Respiratory
Syncytial Virus infection risk factor
and disease severity. Pediatr Pulmonol 2002;
33:458-65.
8. Callegaro S, Andreola B, Matroiacovo P, et
al. Quale aderenza alle raccomandazioni di una
linea guida per la gestione della bronchiolite
acuta? Risultati di uno studio multicentrico italiano.
Pneumologia Pediatrica 2008;29:21-31.
9. Shawn LR, Allan S, Lieberthal H, et al. Clinical
Practice Guideline. The Diagnosis, Management,
and Prevention of Bronchiolitis.
American Academy of Pediatrics (AAP). Pediatrics
2014;134(5):e1474-502.
10. Koehoorn M, Karr CJ, Demers P A, Lencar
C, Tamburic L, Brauer M. Descriptive epidemiological
features of bronchiolitis in a population-
based cohort. Pediatrics 2008;122(6):
1196-203.
11. Kristjansson S, Lodrup Carlsen KC, Wennergren
G, Strannegard IL, Carlsen KH. Nebulised
racemic adrenaline in the treatment of
acute bronchiolitis in infants and toddler. Arch
Dis Child 1993;69;650-4.
12. Mocchi M, Gianiorio P, Cartosio ME, et al.
Terapia della bronchiolite come modello di integrazione
ospedale-territorio. Area Pediatrica
2007;7:7-10.
13. Macchiaiolo M, Cascioli E, Viola L, Mastroiacovo
P. Gestione del bambino con bronchiolite:
un approccio basato sull’evidenza.
Medico e Bambino 1999;18:291-8.
14. Assessorato Politiche per la Salute, Regione
Emilia-Romagna. L’abitudine al fumo di sigaretta
in Emilia-Romagna: dati del sistema di
sorveglianza PASSI (anni 2009-12). www.epicentro.
iss.it/passi/pdf2013/Fumo_PassiER_
09_12.pdf.
15. Sacchetti R, Faccin F, Gregori G, et al. Fumo
passivo e salute dei bambini: cosa succede
a Piacenza. Risultati dello studio Aria Pulita 2.
Quaderni acp 2012;19(1)4-7.
16. Giunta Regionale Direzione Generale Sanità
e Politiche Sociali. Prevalenza dell’allattamento
al seno e altri interventi preventivi in
Emilia Romagna, Ricerca triennale-anno 2011.
www.saluter.it/documentazione/rapporti/allattamento-
al-seno-er-2011.
17. Skelton R, Holland P, Darowski M, et al.
Abnormal surfactant composition and activity
in severe bronchiolitis. Acta Paediatr 1999;
88:942.
18. Panizon F. Dieci anni di novità in Pediatria
ambulatoriale. Medico e Bambino 2001;20:
296-301.
19. Halna M, Leblond P, Aisse E, et al. Impact
of the consensus conference and the ambulatory
treatment of bronchiolitis in infants.
Press Med 2005;34(4):277-81.
20. Mittal V, Darnell C, Walsh B, et al. Inpatient
bronchiolitis guideline implementation
and resource utilization. Pediatrics 2014;133
(3):e730-7.
21. Parikh K, Hall M, Teach SJ. Bronchiolitis
management before and after the AAP guidelines.
Pediatrics 2014;133:e1-7.
22. Fernandes RM, Bialy LM, Vandermeer B,
et al. Glucocorticoids for acute viral bronchiolitis
in infants and young children. Cochrane
database Syst Rev 2013;6:CD004878.
23. Zhanq L, Mendoza-Saai RA, Wainwright C,
et al. Nebulised hypertonic saline solution for
acute bronchiolitis in infants. Cochrane database
Syst Rev 2013;7:CD006458.
24. Chen YJ, Lee WL, Wang CM, Chou HH.
Nebulized hypertonic treatment reduce both
rate and duration of hospitalization for acute
bronchiolitis in infants: an updated metaanalysis.
Pediatr Neonatol 2014;55:431-8.
25. Baraldi E, Lanari M, Manzoni P, et al. Intersociety
consensus document on treatment
and prevention of bronchiolitis in newborns
and infants. Ital J Pediatr 2014;40:65.
Corrispondenza: rosacc@tin.it